Nature Search

Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT₂ Antagonist Ketanserin in Healthy Humans

Matthias E Liechti
Matthias R Saur
Franz X Vollenweider
Research01 Oct 2000
Neuropsychopharmacology

Volume: 23, P: 396-404
Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers

Boris B Quednow
Michael Kometer
Franz X Vollenweider
Research28 Sept 2011
Neuropsychopharmacology

Volume: 37, P: 630-640
3,4-Methylenedioxymethamphetamine (MDMA) Modulates Cortical and Limbic Brain Activity as Measured by [H₂¹⁵O]-PET in Healthy Humans

Alex Gamma
Alfred Buck
Franz X Vollenweider
Research01 Oct 2000
Neuropsychopharmacology

Volume: 23, P: 388-395
Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram

Matthias E Liechti
Christine Baumann
Franz X Vollenweider
Research01 May 2000
Neuropsychopharmacology

Volume: 22, P: 513-521
Effects of the 5-HT_2A Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia

Daniel Umbricht
Franz X Vollenweider
Rene Koller
Research16 Dec 2003
Neuropsychopharmacology

Volume: 28, P: 170-181
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

In this Perspective, Vollenweider and Kometer discuss the clinical potential of psychedelic drugs for the treatment of various psychiatric disorders, and describe the molecular mechanisms by which classical hallucinogens and dissociative anaesthetics affect serotonin and glutamate systems. An interview with Franz X. Vollenweider for Neuropod is available for download.

Franz X. Vollenweider
Michael Kometer
Reviews18 Aug 2010
Nature Reviews Neuroscience

Volume: 11, P: 642-651
Effects of MDMA (Ecstasy) on Prepulse Inhibition and Habituation of Startle in Humans after Pretreatment with Citalopram, Haloperidol, or Ketanserin

Matthias E Liechti
Mark A Geyer
Franz X Vollenweider
Research01 Mar 2001
Neuropsychopharmacology

Volume: 24, P: 240-252
5-HT Modulation of Dopamine Release in Basal Ganglia in Psilocybin-Induced Psychosis in Man—A PET Study with [¹¹C]raclopride

Franz X Vollenweider
Peter Vontobel
Klaus L Leenders
Research01 May 1999
Neuropsychopharmacology

Volume: 20, P: 424-433
Neural mechanisms of psychedelic visual imagery

Devon Stoliker
Katrin H. Preller
Adeel Razi
ResearchOpen Access11 Jun 2024
Molecular Psychiatry

Volume: 30, P: 1259-1266
The Effects of the Preferential 5-HT2A Agonist Psilocybin on Prepulse Inhibition of Startle in Healthy Human Volunteers Depend on Interstimulus Interval

Franz X Vollenweider
Philipp A Csomor
Boris B Quednow
Reviews14 Feb 2007
Neuropsychopharmacology

Volume: 32, P: 1876-1887
Haloperidol Differentially Modulates Prepulse Inhibition and P50 Suppression in Healthy Humans Stratified for Low and High Gating Levels

Philipp A Csomor
Renée R Stadler
Franz X Vollenweider
Research25 Apr 2007
Neuropsychopharmacology

Volume: 33, P: 497-512
Mismatch Negativity Encoding of Prediction Errors Predicts S-ketamine-Induced Cognitive Impairments

André Schmidt
Rosilla Bachmann
Franz X Vollenweider
Research26 Oct 2011
Neuropsychopharmacology

Volume: 37, P: 865-875
Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

Franz X Vollenweider
Alex Gamma
Theo Huber
Research01 Oct 1998
Neuropsychopharmacology

Volume: 19, P: 241-251
Functional brain networks reflect spatial and temporal autocorrelation

Individual variation in fMRI-derived brain networks is reproduced in a model using only the smoothness (autocorrelation) of the fMRI time series. Smoothness has implication for aging and can be causally manipulated by psychedelic serotonergic drugs.

Maxwell Shinn
Amber Hu
John D. Murray
Research24 Apr 2023
Nature Neuroscience

Volume: 26, P: 867-878
Modulating the Rate and Rhythmicity of Perceptual Rivalry Alternations with the Mixed 5-HT_2A and 5-HT_1A Agonist Psilocybin

Olivia L Carter
John D Pettigrew
Franz X Vollenweider
Research26 Jan 2005
Neuropsychopharmacology

Volume: 30, P: 1154-1162
Influence of Aripiprazole, Risperidone, and Amisulpride on Sensory and Sensorimotor Gating in Healthy ‘Low and High Gating’ Humans and Relation to Psychometry

Philipp A Csomor
Katrin H Preller
Franz X Vollenweider
Research07 May 2014
Neuropsychopharmacology

Volume: 39, P: 2485-2496
Caveat Emptor: Editors Beware

Franz X Vollenweider
Reese T Jones
Matthew J Baggott
Correspondence01 Apr 2001
Neuropsychopharmacology

Volume: 24, P: 461-463
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders

A resurgence in interest in the therapeutic potential of psychedelic drugs has boosted research into their neurobiological and cognitive effects. Vollenweider and Preller review recent advances in the field and consider the implications of recent discoveries for the therapeutic use of psychedelics.

Franz X. Vollenweider
Katrin H. Preller
Reviews14 Sept 2020
Nature Reviews Neuroscience

Volume: 21, P: 611-624
Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences

Nathalie M. Rieser
Ladina P. Gubser
Katrin H. Preller
ResearchOpen Access14 Oct 2023
Scientific Reports

Volume: 13, P: 1-12
Author Correction: Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation

Berit Singer
Daniel Meling
Milan Scheidegger
Amendments and CorrectionsOpen Access23 Apr 2024
Scientific Reports

Volume: 14, P: 1
Correction: Neural mechanisms of psychedelic visual imagery

Devon Stoliker
Katrin H. Preller
Adeel Razi
Amendments and CorrectionsOpen Access21 Nov 2024
Molecular Psychiatry

Volume: 30, P: 1714
LSD-induced increases in social adaptation to opinions similar to one’s own are associated with stimulation of serotonin receptors

Patricia Duerler
Leonhard Schilbach
Katrin H. Preller
ResearchOpen Access22 Jul 2020
Scientific Reports

Volume: 10, P: 1-11
Is A Single Dose of MDMA Harmless

Franz X Vollenweider
Alex Gamma
Theo Huber
Correspondence01 Oct 1999
Neuropsychopharmacology

Volume: 21, P: 598-600
Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation

Berit Singer
Daniel Meling
Milan Scheidegger
ResearchOpen Access26 Mar 2024
Scientific Reports

Volume: 14, P: 1-17
Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat

Lukasz Smigielski
Michael Kometer
Franz X. Vollenweider
ResearchOpen Access24 Oct 2019
Scientific Reports

Volume: 9, P: 1-13

Search

Filter By:

Search

Quick links